A comparison of intubation conditions and time-course of action with rocuronium and mivacurium for day case anaesthesia

European Journal of Anaesthesiology

Volumn 24, Issue 6, 2007, Pages 546-550

  Pendeville, P E ^a   Lois, F ^a   Scholtes, J L ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Ambulatory surgery; Anaesthesia general; Neuromuscular blocking agents, mivacurium, rocuronium

Indexed keywords

CHOLINESTERASE; MIVACURIUM; NITROUS OXIDE; PROPOFOL; ROCURONIUM; SUFENTANIL;

ADULT; ANESTHESIA; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INTUBATION; LARYNGOSCOPY; LIMB MOVEMENT; MALE; MYOGRAPHY; NERVE STIMULATION; NEUROMUSCULAR TRANSMISSION; ULNAR NERVE; VOCAL CORD;

ADOLESCENT; ADULT; AMBULATORY SURGICAL PROCEDURES; ANDROSTANOLS; ANESTHESIA, GENERAL; DENMARK; FEMALE; HUMANS; INTUBATION, INTRATRACHEAL; ISOQUINOLINES; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 34249097393     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506002341     Document Type: Article

References (28)

1. Savarese JJ, Kitz RJ. The quest for a short-acting non-depolarising neuromuscular blocking agent. Acta Anaesthesiol Scand 1973; 53: 43-58.
2. Pollard BJ, Chetty MS, Wilson A, Healy TEJ. Intubating conditions and time-course of action of low-dose rocuronium bromide in day-case dental surgery. Europ J Anaesthesiol 1995; 12(11): 81-83.
3. Scheller MS, Zornow MH, Saidman LJ. Tracheal intubation without the use of muscle relaxants: a technique using propofol and varying doses of alfentanil. Anesth Analg 1992; 75: 788-793.
4. Savarese JJ, Ali HH, Basta SJ et al. The clinical neuromuscular pharmacology of mivacurium bromide (BW1090U). Anesthesiology 1988; 68: 723-732.
5. Pino RM, Ali HH, Denman WT, Barrett PS, Schwarz A. A comparison of the intubation conditions between mivacurium and rocuronium during balanced anesthesia. Anesthesiology 1998; 88: 673-678.
6. Prien Th, Zahn P, Menges M, Brüssel Th. 1xD90 dose of rocuronium bromide: tracheal intubation conditions and time-course of action. Eur J Anaesthesiol 1995; 12: 85-90.
7. Pühringer FK, Khuenl-Brady KS, Koller J, Mitterschiffhaler G. Evaluation of the endotracheal intubating conditions of rocuronium and succinylcholine in outpatient surgery. Anesth Analg 1992; 75: 37-40.
8. Tang J, Joshi GP, White PF. Comparison of rocuronium and mivacurium to succinylcholine during outpatient laparoscopic surgery. Anesth Analg 1996; 82: 994-998.
9. Mellinghoff H, Diefenbach C, Bischoff A, Grond S, Buzello W. Dose-response relationship of rocuronium bromide during intravenous anaesthesia. Eur J Anaesthesiol 1994; 11(Suppl 9): 20-24.
10. Meistelman C, Plaude B, Donati F. Rocuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anesthesia 1992; 39: 665-669.
11. Wierda JMKH. Rocuronium for muscle relaxation in ambulatory patients. In: Crul JF, ed. Clinical Aspects of Rocuronium Bromide. Turnhout, Belgium: Interface, 1996: 19-27.
12. Barclay K, Eggers K, Asai T. Low-dose rocuronium improves conditions for tracheal intubation after induction or anaesthesia with propofol and alfentanil. Br J Anaesth 1997; 78(1): 92-94.
13. -1 in adult patients with and without renal failure. Eur J Anaesthesiol 2005; 22: 929-932.
14. Booij LHD, Knape HTA. The neuromuscular blocking effect of Org 9426. A new intermediately-acting steroidal non depolarising muscle relaxant in man. Anaesthesia 1991; 46: 341-343.
15. 2-sufentanil anesthesia. Anesth Analg 1994; 78: 318-321.
16. Ostergaard D, Jensen E, Jensen FS et al. The duration of action of mivacurium induced block in patients homozygous for the atypical plasma cholinesterase gene. Anesthesiology 1991; 75: A774.
17. Goudsouzian NG, D'Hollander AA, Viby-Mogensen J. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 1993; 77(1): 183-185.
18. Cook DR, Freeman JA, Lai AA et al. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 1992; 69(6): 580-585.
19. Khuenl-Brady KS, Pomaroli A, Pühringer F et al. The use of rocuronium in patients with chronic renal failure. Anaesthesia 1993; 48: 873-875.
20. Cooper RA, Maddineni VR, Mirakhur RK et al. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 1993; 71: 222-226.
21. -1 in adult patients with and without renal failure. Eur J Anaesthesiol 2005; 22: 929-932.
22. Khalil M, D'Honneur G, Duvaldestin P et al. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology 1994; 80: 1241-1247.
23. Magorian T, Wood P, Caldwell J et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg 1995; 80: 754-759.
24. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99: 536-545.
25. Laxenaire MC, Mertes PM. Anaphylaxis during anaesthesia: results of a two-year survey in France. Br J Anaesth 2001; 87: 549-558.
26. Guttormsen AB. Allergic reactions during anaesthesia: increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001; 45: 1189-1190.
27. Garvey LH, Roed-Petersen J, Menne T, Husum B. Danish Anaesthesia Allergy Centre: preliminary results. Acta Anaesthesiol Scand 2001; 45: 1204-1209.
28. Bhananker SM, O'Donnell JT, Salemi JR, Bishop MJ. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of Food and Drug Administration reporting of adverse events. Anesth Analg 2005; 101: 819-822.